Hematologist for Elevated Hematocrit
For elevated hematocrit, you should consult a hematologist, as this specialist has the expertise to distinguish between primary polycythemia vera (PV), secondary polycythemia, and relative polycythemia, and can guide the diagnostic workup and management 1.
Why a Hematologist?
Elevated hematocrit requires systematic evaluation to determine its underlying cause, which directly impacts treatment and prognosis. A hematologist is specifically trained to:
Differentiate primary from secondary causes: The diagnostic algorithm for polycythemia requires interpretation of serum erythropoietin (EPO) levels, bone marrow examination, and JAK2 mutation testing—all within the hematologist's scope of practice 1, 2.
Manage polycythemia vera: If PV is diagnosed (present in ~95% of cases with JAK2V617F mutation), hematologists provide specialized treatment including phlebotomy, cytoreductive therapy, and management of complications like thrombosis 1, 3, 2.
Assess thrombotic risk: Hematocrit >60% in men or >55% in women always indicates absolute polycythemia and carries significant thrombotic risk requiring expert management 1, 4.
When to Suspect Polycythemia Requiring Hematology Referral
Refer to hematology if any of the following are present 1:
- Hemoglobin/hematocrit >95th percentile for sex and race
- Documented increase above baseline regardless of absolute value
- PV-related features with borderline-high hematocrit:
- Thrombocytosis or leukocytosis
- Splenomegaly
- Aquagenic pruritus (itching after water contact)
- Unusual thrombosis (Budd-Chiari syndrome)
- Erythromelalgia
- Microcytosis from iron deficiency
The Diagnostic Algorithm Hematologists Follow
First step: Measure serum EPO level 1
- Low EPO: Highly suggestive of PV (>90% specificity), proceed to bone marrow examination
- Normal EPO: PV still possible (EPO sensitivity for PV <70%), proceed to bone marrow examination
- High EPO: Suggests secondary polycythemia, investigate underlying causes
Second step: Bone marrow examination with cytogenetics 1
- Experienced hematopathologists identify characteristic PV changes: hypercellularity, increased megakaryocytes, cluster formation, pleomorphism
Third step: JAK2 mutation testing 2
- JAK2V617F present in ~95% of PV cases
- Presence essentially confirms diagnosis when combined with elevated hematocrit
Common Pitfalls to Avoid
Don't order red cell mass (RCM) studies routinely: These are costly, rarely necessary, and can miss PV cases at the left tail of the distribution 1. Hematocrit >60% always indicates increased RCM unless obvious hemoconcentration exists.
Don't assume smoking or dehydration explains everything: While smoking is the most common cause of elevated hematocrit 4, PV must be excluded, especially with associated features like splenomegaly or thrombocytosis.
Don't delay referral for "borderline" values: If upper-normal hematocrit occurs with any PV-related feature, pursue diagnosis regardless of the specific hematocrit level 1.
Role of Other Specialists
While hematology takes the lead, other specialists may be involved depending on findings:
- Pulmonology: If secondary polycythemia from chronic lung disease is suspected 1
- Nephrology: For renal artery stenosis or post-renal transplant erythrocytosis 1
- Cardiology: For cyanotic congenital heart disease causing secondary polycythemia 1, 5
However, initial evaluation and coordination should be managed by hematology, as they can best interpret the diagnostic algorithm and determine when other specialists are needed 1.